| 1 |
32039920 | D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson's disease. | 2020 Mar 2 |
1 |
| 2 |
31311029 | Expression of Dopamine Receptors in Immune Regulatory Cells. | 2019 |
1 |
| 3 |
23041629 | PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking. | 2012 Nov |
2 |
| 4 |
22028687 | L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission. | 2011 |
2 |
| 5 |
20808799 | Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia. | 2010 Aug 23 |
1 |
| 6 |
19028082 | Comparison of the enantiomers of (+/-)-doxanthrine, a high efficacy full dopamine D(1) receptor agonist, and a reversal of enantioselectivity at D(1) versus alpha(2C) adrenergic receptors. | 2009 Feb |
1 |
| 7 |
17350277 | Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates. | 2007 May |
1 |
| 8 |
17055481 | Histamine H3 receptor agonist- and antagonist-evoked vacuous chewing movements in 6-OHDA-lesioned rats occurs in an absence of change in microdialysate dopamine levels. | 2006 Dec 15 |
2 |
| 9 |
15514976 | Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. | 2005 Jan |
1 |
| 10 |
14705122 | Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. | 2004 Jan |
2 |
| 11 |
2138080 | Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia. | 1990 |
1 |
| 12 |
2871516 | Differential effect of repeated treatment with L-dopa on dopamine-D1 or -D2 receptors. | 1986 Mar |
1 |